⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Starting a GLP-1 medication like Ozempic (semaglutide) or Mounjaro (tirzepatide) is rarely a "set it and forget it" process. Both medications use a careful dose escalation protocol — starting at a low dose and gradually increasing over several weeks or months. This process is called titration, and it exists for a crucial reason: it significantly reduces the nausea, vomiting, and diarrhoea that are the most common reasons people stop GLP-1 therapy before they see real results.
In India, dose titration is often poorly understood. Some patients increase doses too quickly hoping to see faster results. Others stay at a low starting dose indefinitely, missing the therapeutic benefit. This guide helps Indian patients on semaglutide and tirzepatide navigate dose escalation safely — including schedules, cost implications, and what to expect at each step. Consult your healthcare provider before starting any medication or changing your dose.
GLP-1 receptors in the gut, brain, and pancreas need time to adapt to the medication. Starting at a full therapeutic dose immediately causes:
The titration schedule is not optional — it is the clinical protocol established in the SUSTAIN trials (semaglutide) and SURPASS trials (tirzepatide) that demonstrated the medications' safety and efficacy.
Ozempic is available in India as 0.25 mg, 0.5 mg, and 1 mg pre-filled injection pens. The 2 mg dose is available in select urban pharmacies in metros like Mumbai, Delhi, Bengaluru, and Chennai.
| Week | Dose | Purpose |
|---|---|---|
| 1–4 | 0.25 mg weekly | Starting dose — not yet therapeutic |
| 5–8 | 0.5 mg weekly | First therapeutic dose |
| 9–12 | 0.5 mg or 1 mg | Increase only if well tolerated |
| 13 onwards | 1 mg weekly | Standard maintenance dose |
| Optional | 2 mg weekly | Only if prescribed for additional weight loss |
Indian pricing note: A 0.25 mg Ozempic pen (4 doses) costs approximately ₹8,000–₹11,000. A 1 mg pen (4 doses) costs approximately ₹12,000–₹16,000. Moving to higher doses substantially increases the monthly cost.
Mounjaro is available in India in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg autoinjector pens. Not all strengths are consistently available in all cities — supply of higher doses (10 mg, 12.5 mg, 15 mg) can be limited outside major metros.
| Week | Dose | Notes |
|---|---|---|
| 1–4 | 2.5 mg weekly | Mandatory starting dose |
| 5–8 | 5 mg weekly | First therapeutic dose |
| 9–12 | 7.5 mg weekly | Increase if needed and tolerated |
| 13–16 | 10 mg weekly | Continue escalation as needed |
| 17–20 | 12.5 mg weekly | For additional weight loss |
| 21 onwards | 15 mg weekly | Maximum approved dose |
Important: Not everyone needs to reach the maximum dose. Many Indian patients achieve their target weight or glycaemic control at 5 mg or 7.5 mg.
Indian pricing note: Mounjaro pens cost ₹5,000–₹9,000 per pen depending on the dose and pharmacy. Monthly costs at 15 mg can exceed ₹35,000 without insurance coverage.
Do not rush. If you are on 0.25 mg Ozempic, complete all four weeks before increasing — even if you feel fine and are not experiencing side effects. The liver, kidneys, and gastrointestinal system need this time to adapt.
Before every dose increase, honestly evaluate:
If you answer yes to any of these, do not increase the dose yet. Stay at the current dose for an additional 2–4 weeks and contact your prescribing doctor.
Continue injecting on the same day each week. Changing the injection day during a dose escalation week adds unpredictability to absorption and side effects.
The first 48–72 hours after a dose increase are when side effects are most likely to peak. During this window:
1. Increasing the dose too quickly to "speed up results" This is the most common and damaging mistake Indian patients make. Weight loss with GLP-1 medications continues to build over 6–12 months and is not proportional to dose alone. Rushing escalation dramatically increases the risk of severe side effects and early dropout.
2. Skipping a dose, then resuming at a higher level If you missed a dose this week, restart at the dose you were on — not the next higher dose. Discuss with your doctor.
3. Believing you must reach the maximum dose Clinical trials show that many patients achieve significant weight loss at moderate doses. Your doctor will determine the right maintenance dose based on your individual response, not a standard number.
4. Not disclosing side effects to your doctor In India, patients sometimes avoid reporting severe nausea or vomiting because they worry the doctor will stop the medication. Your doctor needs this information. Anti-nausea medications like ondansetron or domperidone can be prescribed to support you through the escalation without stopping GLP-1 therapy.
5. Changing injection site and injection day simultaneously during escalation Changing both variables at once makes it harder to identify the cause if side effects worsen. Change one thing at a time.
Seek medical attention if you experience:
Q: Can I stay at a lower dose permanently if I am seeing good results?
Yes. If you are losing weight at a satisfying rate and tolerating the medication well, there is no clinical requirement to increase to a higher dose. Discuss with your endocrinologist or diabetologist to confirm the right maintenance level for you.
Q: What if I accidentally inject a higher dose than prescribed?
Monitor yourself for severe nausea, vomiting, and symptoms of low blood sugar (trembling, sweating, confusion). Contact your doctor promptly. Do not try to "balance" a high dose with a lower injection next week without medical guidance.
Q: My pharmacy is out of stock — can I skip a week?
Try not to skip more than one injection. Contact your doctor's clinic as soon as possible to explore alternatives, including different pharmacy networks in your city or a different brand or formulation. In India, supply shortages are most common for higher-dose Mounjaro pens.
Q: Does the titration schedule differ between Type 2 diabetes and weight management?
For semaglutide, the titration schedule is similar for both indications. For tirzepatide (primarily approved for Type 2 diabetes in India), the same dose escalation applies. Your doctor may pace the schedule more conservatively if your blood glucose levels need careful monitoring during escalation.
Dose titration is the foundation of successful and safe GLP-1 therapy. Patience during the escalation phase pays off — patients who complete the titration as prescribed have significantly better long-term outcomes and fewer early dropouts. Work closely with your prescribing doctor, report side effects honestly, and remember that the goal is sustainable treatment, not the fastest possible dose increase.
Consult your healthcare provider before starting any medication or making changes to your prescribed dose.
